Human Vaccines & Immunotherapeutics (Nov 2022)

Clinical characteristics, health care resource utilization and direct medical costs of Rotavirus hospitalizations in Spain (2013–2018)

  • Javier Arístegui,
  • Santiago Alfayate-Miguelez,
  • Begoña Carazo-Gallego,
  • Elisa Garrote,
  • Laura Díaz-Munilla,
  • Mikel Mendizabal,
  • María Méndez-Hernández,
  • Elia Doménech,
  • Belén Ferrer-Lorente,
  • María Unsaín-Mancisidor,
  • José Tomás Ramos-Amador,
  • Marta Illán-Ramos,
  • Borja Croche-Santander,
  • Fernando Centeno Malfaz,
  • Julián Rodríguez-Suárez,
  • Manuel Cotarelo Suárez,
  • María San-Martín,
  • Jesús Ruiz-Contreras

DOI
https://doi.org/10.1080/21645515.2022.2046961
Journal volume & issue
Vol. 18, no. 5

Abstract

Read online

Rotavirus (RV) is the most common cause of severe gastroenteritis (GE) in infants and young children worldwide and is associated with a significant clinical and economic burden. The objective of this study was to analyze the characteristics, healthcare resource utilization and the direct medical costs related to RVGE hospitalizations in Spain. An observational, multicenter, cross-sectional study was conducted from June 2013 to May 2018 at the pediatric departments of 12 hospitals from different Spanish regions. Children under 5 years of age admitted to the hospital with a confirmed diagnosis of RVGE were selected. Data on clinical characteristics, healthcare resource use and costs were collected from patient records and hospital databases. Most children hospitalized for RVGE did not have any previous medical condition or chronic disease. Forty-seven percent had previously visited the Emergency Room (ER), 27% had visited a primary care pediatrician, and 15% had received pharmacological treatment prior to hospital admission due to an RVGE episode. The average length of a hospital stay for RVGE was 5.6 days, and the mean medical costs of RVGE hospitalizations per episode ranged from 3,940€ to 4,100€. The highest direct medical cost was due to the hospital stay. This study showed a high burden of health resource utilization and costs related to the management of cases of RVGE requiring hospitalization. RV vaccination with high coverage rates should be considered to minimize the clinical and economic impacts of this disease on the health-care system.

Keywords